Respirology

Article	Citations
	122
Reassessing pyrazinamide: Disentangling the myth of dose‐dependent hepatotoxicity and advancing dosing strategies in elderly tuberculosis patients	119
Broadening Our Understanding of Genetic Risk to Interstitial Lung Disease in Understudied Populations	113
World Lung Day 2025—Healthy Lungs, Healthy Life	97
APSR 2024 Abstracts	90
Effectiveness of Perioperative Radiotherapy With Systemic Therapy on Survival of Squamous Cell Lung Cancer Patients With Pathologic N2	73
Response to “Fixed CPAP at 10 cmH2O for OSA: A One‐Size‐Fits‐All Approach?”	58
Influence of Staphylococcal enterotoxin‐specific IgE sensitization on therapeutic efficacy of omalizumab therapy in severe asthma	55
Predicting malignant pleural effusion during diagnostic pleuroscopy with biopsy: A prospective multicentre study	54
The Assessment of Subglottic and Cervical Tracheal Stenosis Using a Novel Point‐of‐Care Ultrasound Method: Measurement of Tracheal Radius Curvature	54
Bayesian adaptive clinical trial designs for respiratory medicine	50
Effectiveness of Active Video Games as a Training Tool in Patients With Interstitial Lung Disease: A Randomised Controlled Trial	46
Issue Information	46
Prevention of droplet dispersal with ‘e‐mask’: A new daily use endoscopic mask during bronchoscopy	44
Limitations of Self‐Reported Data in Evaluating COPD Phenotypes and Cardiovascular Risk	43
Omics technologies to study virus infection and chronic lung diseases	40
Language concordance in healthcare: Beyond just talk	40
Philip Morris International buys inhaler company Vectura to expand reach in electronic cigarettes	39
Trends of global and regional aetiologies, risk factors and mortality of lower respiratory infections from 1990 to 2019: An analysis for the Global Burden of Disease Study 2019	38
Asthma and landscape fire smoke: A Thoracic Society of Australia and New Zealand position statement	38
	37
	37
Predicting Failure: Can Blood Biomarkers Identify Likely Treatment Non‐Responders in IPF?	36
Issue Information	36
	36

Letter from Canada: Global warming and wildfire smoke pollution emerging as major threats to respiratory health	33
Obesity is a major contributing cause of breathlessness in the population	32
The chicken or the egg: Sleep or physical activity?	32
Associations of early life and childhood risk factors with obstructive sleep apnoea in middle‐age	31
Enhancing COPD Care for Women: A Predictive Tool for Palliative Needs	31
Effect of antifibrotic agents on postoperative complications after lung transplantation for idiopathic pulmonary fibrosis	30
Adding some NOVELTY to treatable traits	30
Nitrogen dioxide increases the risk of disease progression in idiopathic pulmonary fibrosis	29
Issue Information	28
A New Opportunity in Respirology	28
From light to sound: Ultrasound outshines Light's criteria for pleural effusions classification	27
Antifibrotics and lung transplantation: A Spanish multicentre case‐controlled study	27
Allele‐specific micro‐RNA‐mediated regulation of ADAM33 in childhood allergic asthma	26
Smoking, respiratory symptoms, lung function and life expectancy: A longitudinal study of ageing	25
Letter From The Philippines—Breathing Life Into the Nation: The Philippine College of Chest Physicians and Its Impact on Respiratory Health	24
Maximising Participation in the Australian National Lung Cancer Screening Program: A Discrete Choice Experiment of Eligible, High‐Risk Individuals	24
Safety and efficacy of bronchial thermoplasty in Australia 5 years post‐procedure	23
Transitional Lung Function Paths in Young Adults: More Opportunities for Prevention?	23
Proposed quality indicators and recommended standard reporting items in performance of EBUS bronchoscopy: An official World Association for Bronchology and Interventional Pulmonology E	23
Singing in and out of COVID	23
	22
Corrigendum	22
Abstract	22
Issue Information	21
Issue Information	21
A Comprehensive Review of Interstitial Lung Abnormalities	20
My Lungs Have Feelings Too!	20
Pneumothorax in Endobronchial Valve Therapy–Still a Lot to Be Learned	20
Issue Information	19
Issue Information	19
Letter from Australia	19
Correction to “Predictive role of neutrophil‐percentage‐to‐albumin, neutrophil‐to‐lymphocyte and eosinophil‐to‐lymphocyte ratios for mortality in patients with COPD: Evidence from NHAN	19
Sleep medicine is more than just obstructive sleep apnoea	19
An additional mechanism enhancing exercise tolerance in interstitial lung disease with high‐flow nasal cannula	19
Thoracic Society of Australia and New Zealand (TSANZ) Is Abrogating Its Leadership Role in Asia‐Pacific	19
	19
Uncontrolled mild‐to‐moderate asthma may not be mild or moderate, or even asthma: The benefits of early phenotyping	19
Severe asthma, more than that?	18
Promotion of physical activity after hospitalization for COPD exacerbation: Aids and barriers	18
A snorkel mask with a 3D‐printed adaptor to HEPA filter was used in a COVID‐19 emergency ward to provide safe respiratory support	18
Chest x‐ray has low sensitivity to detect silicosis in artificial stone benchtop industry workers	17
Corrigendum	17
The 63rd Annual Meeting of the Japanese Respiratory Society	17
Conspiracy Theories, MDTs and Communication	17
Add‐On Dextromethorphan Improves the Effects of Pirfenidone in Bleomycin‐Treated Mice and Patients With Pulmonary Fibrosis	17
The Olympics have arrived: The challenge of exercise‐induced bronchoconstriction in athletes	17
Abstracts	17
Letter from Vietnam	16
Erythromycin Shortage in an NTM ‐Endemic Country: Implications for Bronchiectasis Care and Antimicrobial Stewardship	16
A New Era in the Treatment of Autoimmune Pulmonary Alveolar Proteinosis	16

Efficacy and safety of virtual bronchoscopic navigation with fused fluoroscopy and vessel mapping for access of pulmonary lesions	16
Leading Women in Respiratory Clinical Sciences: Letter From Japan	15
Author Index	15
Letter from the United States: An update on the New York experience with COVID‐19	15
	15
Correction to APSR Annual Conference ‐ 28th Congress of the Asian Pacific Society of Respirology, 7–10 November 2024, Hong Kong. Respirology 29 (Suppl. 3)	15
Author Index	15
	15
Issue Information	15
Hansen's disease and the first patient disease Registry	14
Letter from Korea	14
Transformative radiology: Chest imaging is being re‐defined	14
The United Nations Framework Convention on Climate Change (UNFCCC) 28th Conference of the Parties, Dubai (COP28): Implications for lung disease	14
	14
Innovations in thoracic imaging: CT, radiomics, AI and x‐ray velocimetry	13
High Flow Nasal Oxygen and Low Flow Oxygen Are Equally Effective in Providing Oxygenation During Bronchoscopy Under Conscious Sedation: A Randomised Controlled Trial	13
Validation of the clinical utility of sGaw as a response variable in methacholine challenge testing	13
Presence of anti‐modified protein antibodies in idiopathic pulmonary fibrosis	13
Predictors of psychological stress in silica‐exposed workers in the artificial stone benchtop industry	13
Feasibility of a Modified Bronchoscopic Transparenchymal Nodule Access Technique (‘Essen Tunnel’) for Improving the Diagnosis of Intraparenchymal Pulmonary Lesions	13
Association of short‐term exposure to PM1 with hospital admission from total and cause‐specific respiratory diseases	13
	13
Global, regional and national burden of chronic obstructive pulmonary disease over a 30‐year period: Estimates from the 1990 to 2019 Global Burden of Disease Study	12
Issue Information	12
Lung cancer in patients with idiopathic pulmonary fibrosis: A retrospective multicentre study in Europe	12
Prognostic Value of a Cardiopulmonary Exercise Testing‐Derived Summed Score in Idiopathic Pulmonary Fibrosis and Connective Tissue Disease‐Associated Interstitial Lung Disease: A Prospective Cohort St	12
Issue Information	12
Determinants of radiation exposure during mobile cone‐beam CT‐guided robotic‐assisted bronchoscopy	12
Phosphodiesterase 5 inhibitor treatment and survival in interstitial lung disease pulmonary hypertension: A Bayesian retrospective observational cohort study	12
Reply	11
	11
Correction to “APSR Annual Conference ‐ 28th Congress of the Asian Pacific Society of Respirology, 7–10 November 2024, Hong Kong. Respirology 29 (Suppl. 3)”	11
Development and Validation of a Clinical Scoring System Predicting 30‐Day Mortality in Acute Exacerbation of Idiopathic Pulmonary Fibrosis	11
Ηeparan sulphate in infectious and non‐infectious exacerbations of COPD	11
	11
A visit to the gallery	11
Breath‐holding physiology, radiological severity and adverse outcomes in COVID‐19 patients: A prospective validation study	11
Illness, chocolate and Harry Potter	11
Excess iron promotes emergence of foamy macrophages that overexpress ferritin in the lungs of silicosis patients	11
Patients' and Health Professionals' Views on Using Oral Corticosteroids for Asthma: Priorities, Trade‐Offs and Shared Decision‐Making	11
Letter from Iceland	11
Adaptation in real time: Wildfire smoke exposure and respiratory health	10
A Novel Method Using Dual‐Energy Computed Tomography for Detecting Amiodarone‐Induced Lung Injury: A Cohort Pilot Study	10
Current evidence on supranormal lung function: A call for longitudinal research to optimize lung health	10
Chest CT‐assessed comorbidities and all‐cause mortality risk in COPD patients in the BODE cohort	10
Small Airways and Pulmonary Diffusing Capacity Decline in an 8‐Year Longitudinal Population Study	10
Tackling a Lifetime of Risk for OSA	10
The Association Between Use of Inhaled Corticosteroids and Long‐Acting Beta2‐Agonists During Pregnancy and Adverse Fetal Outcomes	10
Contemporary Concise Review 2023: Interstitial lung disease	9
A Mechanistic and Morphologic Approach to Managing Benign Central Airway Obstruction	9
Elevated blood lactate in COPD exacerbations associates with adverse clinical outcomes and signals excessive treatment with β2‐agonists	9
Issue Information	9
Robotic One Anaesthetic Marking And Resection ( ROMAR ): A Novel Approach for Thoracoscopic Sublobar Resection of Peripheral Pulmonary Lesions	9
NT ‐ proBNP and BNP Testing in Pulmonary Arterial Hypertension: Poi	9
Epidemiology of interstitial lung disease in systemic lupus erythematosus in France: A nation‐wide population‐based study over 10 years	9
A comprehensible machine learning tool to differentially diagnose idiopathic pulmonary fibrosis from other chronic interstitial lung diseases	9
Pathways linked to unresolved inflammation and airway remodelling characterize the transcriptome in two independent severe asthma cohorts	9
Safety and efficacy of a novel transbronchial radiofrequency ablation system for lung tumours: One year follow‐up from the first multi‐centre large‐scale clinical trial (BRONC‐RFII	9
Alteplase Dose Assessment for Pleural infection Therapy (ADAPT) Study‐2: Use of 2.5 mg alteplase as a starting intrapleural dose	9
The treatable traits approach to adults with obstructive airways disease in primary and secondary care	8
Consumer engagement—Beyond the usual approaches	8
Thoracic Society of Australia and New Zealand position statement: The safe clinical use of sputum induction for bio‐sampling of the lower airways in children and adults	8
The hidden costs of living with systemic sclerosis‐associated interstitial lung disease	8
Siloed thinking is limiting health care delivery	8
Urban living	8
Effect of an artificial intelligence tool on management decisions for indeterminate pulmonary nodules	8
Contemporary Concise Review 2023: Environmental and occupational lung diseases	8
Smoking: Quit to win	8
Recommendations from the Medical Education Editor	8
Recommendations from The Medical Education Editor	8
Beyond Single Cytokines: Targeting Co‐Receptor CD131 in Asthma‐COPD Overlap	8
The Western Australian Mesothelioma Registry: Analysis of 60 years of cases	8
Inflammation‐induced loss of CFTR‐expressing airway ionocytes in non‐eosinophilic asthma	8
Reply to: ‘Is continuous positive airway pressure truly superior to high‐flow nasal cannula in managing acute hypoxemic respiratory failure?’	8
Cough suppression as a radical but effective therapeutic strategy	8
Breathlessness: Remembering the worst of it	8
Letter from the Czech Republic	8
Looking Towards More Comprehensive Management of Interstitial Lung Disease	8
COPD‐related incidence, mortality, and disability: An illustrative summary of the GBD study (1990–2019)	8
World Association for Bronchology and Interventional Pulmonology (WABIP) guidelines on airway stenting for malignant central airway obstruction	7

Letter from Thailand	7
Bronchoscopic approaches to sampling lung nodules: Aiming for the bulls eye	7
World Lung Day 2023—Access to prevention and treatment for all, leave no one behind	7
Extracellular traps are evident in Romanowsky‐stained smears of bronchoalveolar lavage from children with non‐cystic fibrosis bronchiectasis	7
Increased exacerbations of bronchiectasis following recovery from mild COVID‐19 in patients with non‐cystic fibrosis bronchiectasis	7
Quantitative computed tomography of the chest for fibrotic lung diseases: Prime time for its use in routine clinical practice?	7
Into the meaning of Respirology, Pulmonology and Pneumology	7
Home sweet home… or is it?	7
Plastics in Every Breath: The Silent Respiratory Health Threat We Cannot Avoid	7
	7
Understanding Nontuberculous Mycobacterial Pulmonary Disease as a Chronic Lung Disease	7
Effect of chronic mucus hypersecretion on treatment responses to inhaled therapies in patients with chronic obstructive pulmonary disease: Post hoc analysis of the IMPACT trial	7
Is it time to use HFNC oxygen therapy during exercise in IPF patients?	7
Stirring the publishing pot by ending accept/reject decisions	6
Ipsilateral and contralateral hemidiaphragm dynamics in symptomatic pleural effusion: The 2nd PLeural Effusion And Symptom Evaluation (PLEASE‐2) Study	6
Racial and ethnic disparities in antifibrotic therapy in idiopathic pulmonary fibrosis	6
Comparing recalled versus experienced symptoms of breathlessness ratings: An ecological assessment study using mobile phone technology	6
Atomoxetine and fesoterodine combination improves obstructive sleep apnoea severity in patients with milder upper airway collapsibility	6
Issue Information	6
The Case for Case Finding Is Getting Stronger	6
Leading women in respiratory clinical sciences: Letter from Australia	6
Small babies at birth, small lungs for life?	6
Characteristics, goal‐oriented treatments and survival of pulmonary arterial hypertension in China: Insights from a national multicentre prospective registry	6
Pulmonary functional MRI: Detecting the structure–function pathologies that drive asthma symptoms and quality of life	6
Benefits of chest wall mobilization on respiratory efficiency and functional exercise capacity in people with severe chronic obstructive pulmonary disease (COPD): A randomized controlled tr	6
Long‐term trends of COPD mortality: Gaps and opportunities	6
Nintedanib in Asian patients with progressive fibrosing interstitial lung diseases: Results from the INBUILD trial	6
Reliability of Rapid On‐Site Evaluation Achieved by Remote Sharing Systems (E‐ ROSE ) and AI Algor	6
Issue Information	6
Breaking the spiral: How negative mood can fuel exertional breathlessness in people with chronic obstructive pulmonary disease	5
Pre‐transplant anti‐fibrotics for idiopathic pulmonary fibrosis: Are we seeing a new role for the anti‐fibrotics?	5
A snapshot of SABA co‐prescribing with ICS‐formoterol maintenance and reliever therapy	5
Checkpoint inhibitors are a basic science‐based, transformative new treatment for lung cancer	5
Author Index	5
Optimal clinical practice in IPF and PPF: Integrating the scientific ethos and clinical reasoning	5
Quantum Respiratory Science	5
Sputum Metagenomics Reveals Multidrug‐Resistant Pseudomonas‐Dominant Communities in Severe Asthma	5
Vaccination in patients with COPD: COVID has raised the bar	5
	5
Letter From the Vietnam Respiratory Society—Vietnam's Respiratory Medicine in Transition: From Clinical Advances to National Healthcare Policy	5
Pathological Examination and Genetic Mutation Testing: Bridging Their Best Practices Using MINtS	5
	5
Contemporary Concise Review 2021: Interstitial lung disease	5
Letter from Belgium	5
COVID‐19 vaccine‐induced immunity: Head‐to‐head comparison of mRNA (BNT162b2) versus inactivated (CoronaVac) vaccines	5
Letter from the UK: Reflections on a turbulent 5 years	5
Covid‐19 pandemic and asthma: What did we learn?	5
Risk of childhood asthma in those born small	5
	5
Evaluating artificial intelligence responses to respiratory medicine questions	5
Clinical trials and clinical trials networks	5
Safety of pyrazinamide in elderly patients with tuberculosis in Japan: A nationwide cohort study	5
	5
Environmental impact of inhaled medicines: A Thoracic Society of Australia and New Zealand position statement	5
Cardiovascular Effect of Snoring in Asians: What Do Biobank and Genomic Studies Say?	5
Molecular Investigation in Early‐Onset Interstitial Lung Disease: Results From 699 Unrelated Patients	5
Letter from South Africa	5
Issue Information	5
Issue Information	5
Targeting the human βc receptor inhibits inflammatory myeloid cells and lung injury caused by acute cigarette smoke exposure	5
How does one get around many of the confounding factors influencing the response to methacholine?	5
Issue Information	5
Overexpression of SMAD7 improves the function of EGFR‐targeted human CAR‐T cells against non‐small‐cell lung cancer	5
Effect of pulmonary rehabilitation duration on exercise capacity and health‐related quality of life in people with chronic obstructive pulmonary disease (PuRe Duration Trial): A randomized	5
Contemporary Concise Review 2024: Respiratory Infections	5
Objective Effects and Patient Preferences for Ambulatory Oxygen in Fibrotic Interstitial Lung Disease With Isolated Exertional Hypoxaemia: A Placebo‐Controlled 6‐Minute Walk Test Study	5
Correction to “Feasibility of a Modified Bronchoscopic Transparenchymal Nodule Access Technique (‘Essen Tunnel’) for Improving the Diagnosis of Intraparenchymal Pulmonary Lesions”	5
Fixed Pressure Wins Again: Why Obesity Hypoventilation Syndrome Demands Stability	4
Effects of early mobilization on patients with COVID‐19 with respiratory failure	4
Lifetime Body Mass Index Trajectories and Contrasting Lung Function Abnormalities in Mid‐Adulthood: Data From the Tasmanian Longitudinal Health Study	4
Which biologic? New findings from a real‐world study	4
Virtual bronchoscopic navigation and endobronchial ultrasound with a guide sheath without fluoroscopy for diagnosing peripheral pulmonary lesions with a bronchus leading to or adjacent to the lesion:	4
Pre‐Treatment MMP7 Predicts Progressive Idiopathic Pulmonary Fibrosis in Antifibrotic Treated Patients	4
Severe asthma ILC2s demonstrate enhanced proliferation that is modified by biologics	4
Endotyping in sleep surgery: Not ready for primetime	4
Benralizumab and mepolizumab treatment outcomes in two severe asthma clinics	4
PDE5 to keep them alive: The use of phosphodiesterase type‐5 inhibitors in severe pulmonary hypertension associated with interstitial lung disease	4
The role of obstructive sleep apnoea in cognitive dysfunction of the elderly: A therapeutic target or Pandora's box?	4
A paediatric bronchoscopist's ‘Field of Dreams’: Will the flexible cryoprobe hit a home run?	4
Recommendations From the Medical Education Editor	4
Obstructive Sleep Apnoea Treatments—Where Are We Now?	4
Small for gestational age is associated with reduced lung function in middle age: A prospective study from first to fifth decade of life	4
Hypoxic indices for obstructive sleep apnoea severity and cardiovascular disease risk prediction: A comparison and application in a community population	4
Aetiology of Adult Community‐Acquired Lung Abscess in Hong Kong	4
Changes to clinical education during the COVID‐19 pandemic: Challenges and opportunities	4
Diffusion capacity and static hyperinflation as markers of disease progression predict 3‐year mortality in COPD: Results from COSYCONET	4
Nurturing respiratory clinician‐scientists—An important priority in the Asia‐Pacific and for the Asia‐Pacific Society of Respirology (APSR)	4
Leading women in Respiratory Medicine: Letter from the ERS	4
Clinical Presentation and Diagnostic Evaluation of Vaping Related Lung Injury in Youth	4
Response to ‘Reassessing pyrazinamide: Disentangling the myth of dose‐dependent hepatotoxicity and advancing dosing strategies in elderly tuberculosis patients’	4
Prevalence and prognosis of chronic fibrosing interstitial lung diseases with a progressive phenotype	4
Auto‐adjusted versus fixed positive airway pressure in patients with severe OSA: A large randomized controlled trial	4
Rheumatoid factor and anti‐citrullinated antibodies in non‐connective tissue interstitial lung disease: The chicken or the egg?	4
Letter from the Sultanate of Oman	4
Non‐Intubated VATS for Interstitial Lung Disease Diagnosis: A Safer Technique or Too Soon to Tell?	4